---
layout: post
title: "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction"
date: 2026-02-05 18:35:14 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-00390
original_published: 2023-01-11 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** January 11, 2023 00:00 UTC
**Document Number:** 2023-00390

## Summary

The Food and Drug Administration is correcting a notice entitled "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal" that appeared in the Federal Register of December 13, 2022. The document announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/01/11/2023-00390/advisory-committee-cardiovascular-and-renal-drugs-advisory-committee-renewal-correction)
- API: https://www.federalregister.gov/api/v1/documents/2023-00390

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
